£104.44

Springer Esophageal Cancer: Prevention, Diagnosis and Therapy

Price data last checked 15 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£104 today · previous high £104 · all-time low £104

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 76 days · 76 data points (no recent data)

Historical
Generating forecast…
£104.44 £104.15 £104.22 £104.28 £104.34 £104.40 £104.47 25 April 2026 13 May 2026 01 June 2026 20 June 2026 09 July 2026

Price Distribution

Price distribution over 76 days • 1 price levels

Days at Price
76 days 0 19 38 57 76 £104 Days at Price

Price Analysis

Most common price: £104 (76 days, 100.0%)

Price range: £104 - £104

Price levels: 1 different prices over 76 days

Description

The second edition of this very successful book documents the latest progress in the prevention, diagnosis and treatment of esophageal cancer and includes additional sections covering novel targeted therapeutic approaches, immunotherapy and palliative and nutritional support for patients. Furthermore, the sections covering epidemiology, molecular biology, pathology, staging and radiologic and endoscopic assessments have been thoroughly updated and expanded. The principles of surgical resection, radiation therapy and systemic therapy are reviewed and attention is paid to the multidisciplinary approaches to the management of early stage cervical, thoracic, distal and junctional tumors. Updated information is also provided on the treatment of metastatic and recurrent disease as well as approaches that may impact future care, such as chemoprevention. Esophageal Cancer: Prevention, Diagnosis and Therapy will assist specialists from various disciplines, including surgery, radiation therapy, gastroenterology, medical oncology and palliative medicine, in delivering optimal, up-to-date care to the benefit of patients. From the Back Cover The second edition of this very successful book documents the latest progress in the prevention, diagnosis and treatment of esophageal cancer and includes additional sections covering novel targeted therapeutic approaches, immunotherapy and palliative and nutritional support for patients. Furthermore, the sections covering epidemiology, molecular biology, pathology, staging and radiologic and endoscopic assessments have been thoroughly updated and expanded. The principles of surgical resection, radiation therapy and systemic therapy are reviewed and attention is paid to the multidisciplinary approaches to the management of early stage cervical, thoracic, distal and junctional tumors. Updated information is also provided on the treatment of metastatic and recurrent disease as well as approaches that may impact future care, such as chemoprevention. Esophageal Cancer: Prevention, Diagnosis and Therapy will assist specialists from various disciplines, including surgery, radiation therapy, gastroenterology, medical oncology and palliative medicine, in delivering optimal, up-to-date care to the benefit of patients. About the Author Nabil F. Saba, MD, FACP, is an internationally recognized leader in the treatment of head and neck and esophageal cancer.  He is Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine and Director of the Head and Neck Cancer Medical Oncology Program at the Winship Cancer Institute of Emory University. Dr. Saba has led several institutional and national trials in head and neck and esophageal cancer and chaired a number of NCI cooperative group trials. He has been elected Chair of the National Cancer Institute Head and Neck Cancer Steering Committee’s task force on rare tumors and is a member of the NRG and ECOG Head and Neck Cancer core committees as well as the NCI steering committee’s task force on recurrent metastatic head and neck cancer. Dr. Saba has authored more than 150 peer-reviewed articles, editorials, review papers and book chapters. He is a member of the editorial boards of Cancer, Oral Oncology, Head Neck, American Journal of Clinical Oncology and Cancers of the Head and Neck. Bassel F. El-Rayes, MD, is Professor and Vice Chair in the Department of Hematology and Medical Oncology at Emory University School of Medicine and Associate Cancer Center Director for Clinical Research at Winship Cancer Institute of Emory University. He is Director of the GI Cancer Program at Winship Cancer Institute. Dr. El-Rayes has focused on translational drug development research in the area of GI malignancies, including esophageal cancer. He has been principal investigator on a number of institutional and multi-institutional trials. He has served on the NCI Neuroendocrine Tumor Task Force

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
10 December 2019
Listed Since
23 July 2019

Barcode

No barcode data available

Similar Products You Might Like

Contemporary Management of Esophageal and Gastric Cancer, An Issue of Surgical Oncology Clinics of North America: Volume 33-3 (The Clinics: Surgery, Volume 33-3)
96% match

Contemporary Management of Esophageal and Gastric Cancer, An Issue of Surgical Oncology Clinics of North America: Volume 33-3 (The Clinics: Surgery, Volume 33-3)

Elsevier

£65.98 02 Jul 2026
Minimally Invasive Foregut Surgery for Malignancy: Principles and Practice
96% match

Minimally Invasive Foregut Surgery for Malignancy: Principles and Practice

Springer

£54.85 15 Jul 2026
Esophageal Cancer: Prevention, Diagnosis and Therapy
96% match

Esophageal Cancer: Prevention, Diagnosis and Therapy

Springer

£107.99 10 Jul 2026
Treatment of Esophageal and Hypopharyngeal Squamous Cell Carcinoma (Updates in Surgery)
96% match

Treatment of Esophageal and Hypopharyngeal Squamous Cell Carcinoma (Updates in Surgery)

Springer

£80.66 04 Jul 2026
Management of Esophageal Cancer, An Issue of Surgical Clinics (Volume 101-3) (The Clinics: Surgery, Volume 101-3)
96% match

Management of Esophageal Cancer, An Issue of Surgical Clinics (Volume 101-3) (The Clinics: Surgery, Volume 101-3)

Elsevier

£62.85 08 Jul 2026
Carcinoma of the Esophagus and Gastric Cardia
96% match

Carcinoma of the Esophagus and Gastric Cardia

Springer

£78.01 09 Jul 2026
Esophageal Cancer: An Interactive CD-ROM
96% match

Esophageal Cancer: An Interactive CD-ROM

Springer

£114.62 03 Jul 2026
Atlas of Thoracoscopic-lapacoscopic Esophagectomy
95% match

Atlas of Thoracoscopic-lapacoscopic Esophagectomy

Springer

£141.73 01 Jul 2026
Head and Neck Cancer, An Issue of Hematology/Oncology Clinics of North America (Volume 35-5) (The Clinics: Internal Medicine, Volume 35-5)
95% match

Head and Neck Cancer, An Issue of Hematology/Oncology Clinics of North America (Volume 35-5) (The Clinics: Internal Medicine, Volume 35-5)

Elsevier

£72.20 03 Jul 2026
Esophageal Cancer: Diagnosis and Treatment
95% match

Esophageal Cancer: Diagnosis and Treatment

Springer

£62.56 04 Jul 2026
Laryngeal Cancer: An Interdisciplinary Resource for Practitioners
95% match

Laryngeal Cancer: An Interdisciplinary Resource for Practitioners

Slack

£56.15 08 Jul 2026
A Mastery Approach to Complex Esophageal Diseases
95% match

A Mastery Approach to Complex Esophageal Diseases

Springer

£68.35 04 Jul 2026
Demos Medical Head and Neck Cancers: Evidence-Based Treatment
95% match

Demos Medical Head and Neck Cancers: Evidence-Based Treatment

Demos Medical Publishing

£120.48 15 Jul 2026
Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)
95% match

Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)

Academic Press

£112.58 10 Jul 2026
Adenocarcinoma of the Esophagogastric Junction: From Barrett's Esophagus to Cancer
95% match

Adenocarcinoma of the Esophagogastric Junction: From Barrett's Esophagus to Cancer

Springer

£75.55 06 Jul 2026
Carcinoma of the Larynx and Hypopharynx
95% match

Carcinoma of the Larynx and Hypopharynx

Springer

£88.19 10 Jul 2026
Head and Neck Cancer: Treatment, Rehabilitation, and Outcomes
95% match

Head and Neck Cancer: Treatment, Rehabilitation, and Outcomes

Plural Publishing

£127.00 09 Jul 2026
Cancer of the Liver, Esophagus, and Nasopharynx
95% match

Cancer of the Liver, Esophagus, and Nasopharynx

Springer

£70.66 07 Jul 2026
Atlas of Esophageal Surgery
95% match

Atlas of Esophageal Surgery

Springer

£65.29 03 Jul 2026
Malignancies of the Upper Gastrointestinal Tract, An Issue of Hematology/Oncology Clinics of North America: Volume 38-3 (The Clinics: Internal Medicine, Volume 38-3)
95% match

Malignancies of the Upper Gastrointestinal Tract, An Issue of Hematology/Oncology Clinics of North America: Volume 38-3 (The Clinics: Internal Medicine, Volume 38-3)

Elsevier

£73.76 04 Jul 2026
Targeted Therapies in Oncology
95% match

Targeted Therapies in Oncology

CRC Press

£62.60 02 Jul 2026
Atlas of Thoracoscopic-lapacoscopic Esophagectomy
95% match

Atlas of Thoracoscopic-lapacoscopic Esophagectomy

Springer

£103.26 16 Jul 2026
Obesity and Esophageal Disorders
95% match

Obesity and Esophageal Disorders

Academic Press

£107.56 10 Jul 2026
Adenocarcinoma of the Esophagogastric Junction: 182 (Recent Results in Cancer Research, 182)
95% match

Adenocarcinoma of the Esophagogastric Junction: 182 (Recent Results in Cancer Research, 182)

Springer

£80.66 09 Jul 2026